IRIS

Sfoglia per Rivista  ALIMENTARY PHARMACOLOGY

Opzioni
Vai a: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Mostrati risultati da 50 a 69 di 102
Titolo Data di pubblicazione Autore(i) File
Letter: corticosteroid use alongside tofacitinib in OCTAVE Open. Authors' reply 1-gen-2020 Sands, Bruce E; Armuzzi, Alessandro; Marshall, John K; Lindsay, James O; Sandborn, William J; Danese, Silvio; Panés, Julián; Bressler, Brian; Colombel, Jean-Frédéric; Lawendy, Nervin; Maller, Eric; Zhang, Haiying; Chan, Gary; Salese, Leonardo; Tsilkos, Konstantinos; Marren, Amy; Su, Chinyu
Letter: European Medicines Agency recommendations for allergic reactions to intravenous iron-containing medicines 1-gen-2014 Gomollon, F; Chowers, Y; Danese, S; Dignass, A; Nielsen, Oh; Lakatos, Pl; Lees, Cw; Lindgren, S; Lukas, M; Mantzaris, Gj; Michetti, P; Moum, B; Peyrin-Biroulet, L; Toruner, M; van der Woude, J; Weiss, G; Stoevelaar, H; Reinisch, W
Letter: immunogenicity of infliximab originator vs. CT-P13 in IBD patients 1-gen-2017 Fiorino, G; Correale, C; Radice, S; Allocca, M; Furfaro, F; Gilardi, D; Nagore, D; Del Rio, L; Pascual, J; Martinez, A; Danese, S
Letter: infliximab therapy in inflammatory bowel disease patients after liver transplantation 1-gen-2013 Indriolo, A; Fagiuoli, S; Pasulo, L; Fiorino, G; Danese, S; Ravelli, P
Letter: Potassium-competitive acid blockers may increase the risk of gastric cancer after Helicobacter pylori eradication—a retrospective multicentre-cohort analysis. Authors' reply 1-gen-2023 Piovani, D.; Tsantes, A. G.; Schunemann, H. J.; Bonovas, S.
Letter: SARS-CoV-2 infection in two IBD patients treated with dual targeted therapy 1-gen-2021 Privitera, G; Pugliese, D; Scaldaferri, F; Armuzzi, A
Letter: thromboembolic and cardiovascular events with tofacitinib in ulcerative colitis-two cases in real world clinical practice. Authors' reply 1-gen-2020 Sandborn, William J; Panés, Julian; Sands, Bruce E; Reinisch, Walter; Su, Chinyu; Lawendy, Nervin; Koram, Nana; Fan, Haiyun; Jones, Thomas V; Modesto, Irene; Quirk, Daniel; Danese, Silvio
Liver stiffness measurement reliability and main determinants of point shear-wave elastography in patients with chronic liver disease 1-gen-2016 Fraquelli, M.; Baccarin, A.; Casazza, G.; Conti, C. B.; Giunta, M.; Massironi, S.; Invernizzi, F.; Donato, M. F.; Maggioni, M.; Aghemo, A.; Conte, D.; Colombo, M.
A lyophilized and inactivated culture of Lactobacillus acidophilus increases Helicobacter pylori eradication rates 1-gen-2000 Canducci, F; Armuzzi, A; Cremonini, F; Cammarota, G; Bartolozzi, F; Pola, P; Gasbarrini, G; Gasbarrini, A
Meta-analysis: Use of proton pump inhibitors and risk of gastric cancer in patients requiring gastric acid suppression 1-gen-2023 Piovani, Daniele; Tsantes, Andreas G; Schunemann, Holger J; Bonovas, Stefanos
NOD2/CARD15 gene polymorphisms and Crohn's disease in the Chinese population 1-gen-2003 Leong, Rwl; Armuzzi, A; Ahmad, T; Wong, Ml; Tse, P; Jewell, Dp; Sung, Jjy
Oesophageal motility and bolus transit abnormalities increase in parallel with the severity of gastro-oesophageal reflux disease 1-gen-2011 Savarino, E.; Gemignani, L.; Pohl, D.; Zentilin, P.; Dulbecco, P.; Assandri, L.; Marabotto, E.; Bonfanti, D.; Inferrera, S.; Fazio, V.; Malesci, A.; Tutuian, R.; Savarino, V.
One-week therapy for Helicobacter pylori eradication: ranitidine bismuth citrate plus medium-dose clarithromycin and either tinidazole or amoxycillin 1-gen-1998 Cammarota, G; Cannizzaro, O; Tursi, A; Papa, A; Gasbarrini, A; Cuoco, L; Cianei, R; Armuzzi, A; Fedeli, P; Fedeli, G; Gasbarrini, G
Paradoxical psoriasis in a large cohort of patients with inflammatory bowel disease receiving treatment with anti-TNF alpha: 5-year follow-up study 1-gen-2015 Pugliese, D; Guidi, L; Ferraro, Pm; Marzo, M; Felice, C; Celleno, L; Landi, R; Andrisani, G; Pizzolante, F; De Vitis, I; Papa, A; Rapaccini, Gl; Armuzzi, A
Physicians' perspective on the clinical meaningfulness of inflammatory bowel disease trial results: an International Organization for the Study of Inflammatory Bowel Disease (IOIBD) survey 1-gen-2018 Olivera, P; Sandborn, Wj; Panes, J; Baumann, C; D'Haens, G; Vermeire, S; Danese, S; Peyrin-Biroulet, L
Primary antibiotic resistance in Helicobacter pylori strains isolated in northern and central Italy 1-gen-2007 Zullo, A; Perna, Francesco; Hassan, Cesare; Ricci, C; Saracino, I; Morini, S; Vaira, D.
Primary clarithromycin resistance in Italy assessed on Helicobacter pylori DNA sequences by TaqMan real-time polymerase chain reaction 1-gen-2006 De Francesco, V; Margiotta, M; Zullo, A; Hassan, Cesare; Valle, Nd; Burattini, O; Cea, U; Stoppino, G; Amoruso, A; Stella, F; Morini, S; Panella, C; Ierardi, E.
Proton-pump inhibitor for peptic ulcer bleeding 1-gen-2005 Zullo, A; Hassan, Cesare; Morini, S.
Randomised clinical trial: low-volume bowel preparation for colonoscopy - a comparison between two different PEG-based formulations 1-gen-2012 Repici, A; Cestari, R; Annese, V; Biscaglia, G; Vitetta, E; Minelli, L; Trallori, G; Orselli, S; Andriulli, A; Hassan, C
Randomised clinical trial: mesalazine and/or probiotics in maintaining remission of symptomatic uncomplicated diverticular disease - a double-blind, randomised, placebo-controlled study 1-gen-2013 Tursi, A; Brandimarte, G; Elisei, W; Picchio, M; Forti, G; Pianese, G; Rodino, S; D'Amico, T; Sacca, N; Portincasa, P; Capezzuto, E; Lattanzio, R; Spadaccini, A; Fiorella, S; Polimeni, F; Polimeni, N; Stoppino, V; Stoppino, G; Giorgetti, Gm; Aiello, F; Danese, S
Mostrati risultati da 50 a 69 di 102
Legenda icone

  •  file ad accesso aperto
  •  file disponibili sulla rete interna
  •  file disponibili agli utenti autorizzati
  •  file disponibili solo agli amministratori
  •  file sotto embargo
  •  nessun file disponibile